Cargando…

Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?

Introduction: Immunotherapy is a treatment option for non-small cell lung cancer advanced disease. However; immunotherapy in several patients induces orogonitis and effusion in different cavities. It is up to the treating physician to understand whether there is effusion due to adverse effect or dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Huang, Haidong, Yang, Meng, Zhou, Jun, Jiao, Yang, Wang, Qin, Petridis, Dimitris, Sapalidis, Konstantinos, Sardeli, Chrysanthi, Konsta, Parthenopi, Koulouris, Charilaos, Michalopoulos, Nikolaos, Giannakidis, Dimitrios, Barbetakis, Nikolaos, Katsaounis, Athanasios, Hohenforst-Schmidt, Wolfgang, Amaniti, Aikaterini, Petanidis, Savvas, Tsakiridis, Kosmas, Courcoutsakis, Nikolaos, Goganau, Alexandru Marian, Vagionas, Anastasios, Romanidis, Konstantinos, Oikonomou, Panagoula, Karanikas, Michael, Katsios, Iason Nikolaos, Kesisoglou, Isaak, Kosmidis, Christoforos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995373/
https://www.ncbi.nlm.nih.gov/pubmed/32047566
http://dx.doi.org/10.7150/jca.40004
_version_ 1783493368861425664
author Zarogoulidis, Paul
Huang, Haidong
Yang, Meng
Zhou, Jun
Jiao, Yang
Wang, Qin
Petridis, Dimitris
Sapalidis, Konstantinos
Sardeli, Chrysanthi
Konsta, Parthenopi
Koulouris, Charilaos
Michalopoulos, Nikolaos
Giannakidis, Dimitrios
Barbetakis, Nikolaos
Katsaounis, Athanasios
Hohenforst-Schmidt, Wolfgang
Amaniti, Aikaterini
Petanidis, Savvas
Tsakiridis, Kosmas
Courcoutsakis, Nikolaos
Goganau, Alexandru Marian
Vagionas, Anastasios
Romanidis, Konstantinos
Oikonomou, Panagoula
Karanikas, Michael
Katsios, Iason Nikolaos
Kesisoglou, Isaak
Kosmidis, Christoforos
author_facet Zarogoulidis, Paul
Huang, Haidong
Yang, Meng
Zhou, Jun
Jiao, Yang
Wang, Qin
Petridis, Dimitris
Sapalidis, Konstantinos
Sardeli, Chrysanthi
Konsta, Parthenopi
Koulouris, Charilaos
Michalopoulos, Nikolaos
Giannakidis, Dimitrios
Barbetakis, Nikolaos
Katsaounis, Athanasios
Hohenforst-Schmidt, Wolfgang
Amaniti, Aikaterini
Petanidis, Savvas
Tsakiridis, Kosmas
Courcoutsakis, Nikolaos
Goganau, Alexandru Marian
Vagionas, Anastasios
Romanidis, Konstantinos
Oikonomou, Panagoula
Karanikas, Michael
Katsios, Iason Nikolaos
Kesisoglou, Isaak
Kosmidis, Christoforos
author_sort Zarogoulidis, Paul
collection PubMed
description Introduction: Immunotherapy is a treatment option for non-small cell lung cancer advanced disease. However; immunotherapy in several patients induces orogonitis and effusion in different cavities. It is up to the treating physician to understand whether there is effusion due to adverse effect or disease progression. Pleurodesis in both cases might be a solution for recurrent pleura effusion. Patients and Methods: Three hundred and thirty seven non-small cell lung cancer patients with adenocarcinoma and pleura effusion during first line immunotherapy treatment underwent medical thoracoscopy or Video assisted thoracic surgery (VATS) for pleurodesis with talk poudrage. Uniportal medical thoracoscopy was performed under general with dual channel endotracheal tube in one hundred and eleven patients. Video assisted thoracic surgery was performed in one hundred and eighty seven patients and conversion from medical to VATS procedure was done to thirty nine patients. All patients had stage IV disease with pleura involvement and were under first line pembrolizumab treatment with 200mg (PD-L1 ≥ 50%). Results: The quantitative parameters of the study (expression, PY and cycle) were converted to an ordinal scale to facilitate the performance of statistical analysis. All parameters were examined as dependent against the parameter technique acting as independent to detect potential relationships. The results of multi Y versus X relationship revealed no statistically significant effect (p>0.05) of the three levels of technique against any response considered. Thus we can infer, quite safely, that the innovative operation (level 0) does not differ from the other two conventional methods (levels 2 and 3) through all parameters entered in the model. There was no significant difference between the different pleurodesis techniques. Discussion: Immunotherapy is known to induce in a number of patients pleura effusion and pericarditis. However; pleurodesis is efficient when the appropriate method is performed to every patient. Careful assessment in a case by case manner has to be performed for each patient before any procedure is performed.
format Online
Article
Text
id pubmed-6995373
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-69953732020-02-11 Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? Zarogoulidis, Paul Huang, Haidong Yang, Meng Zhou, Jun Jiao, Yang Wang, Qin Petridis, Dimitris Sapalidis, Konstantinos Sardeli, Chrysanthi Konsta, Parthenopi Koulouris, Charilaos Michalopoulos, Nikolaos Giannakidis, Dimitrios Barbetakis, Nikolaos Katsaounis, Athanasios Hohenforst-Schmidt, Wolfgang Amaniti, Aikaterini Petanidis, Savvas Tsakiridis, Kosmas Courcoutsakis, Nikolaos Goganau, Alexandru Marian Vagionas, Anastasios Romanidis, Konstantinos Oikonomou, Panagoula Karanikas, Michael Katsios, Iason Nikolaos Kesisoglou, Isaak Kosmidis, Christoforos J Cancer Research Paper Introduction: Immunotherapy is a treatment option for non-small cell lung cancer advanced disease. However; immunotherapy in several patients induces orogonitis and effusion in different cavities. It is up to the treating physician to understand whether there is effusion due to adverse effect or disease progression. Pleurodesis in both cases might be a solution for recurrent pleura effusion. Patients and Methods: Three hundred and thirty seven non-small cell lung cancer patients with adenocarcinoma and pleura effusion during first line immunotherapy treatment underwent medical thoracoscopy or Video assisted thoracic surgery (VATS) for pleurodesis with talk poudrage. Uniportal medical thoracoscopy was performed under general with dual channel endotracheal tube in one hundred and eleven patients. Video assisted thoracic surgery was performed in one hundred and eighty seven patients and conversion from medical to VATS procedure was done to thirty nine patients. All patients had stage IV disease with pleura involvement and were under first line pembrolizumab treatment with 200mg (PD-L1 ≥ 50%). Results: The quantitative parameters of the study (expression, PY and cycle) were converted to an ordinal scale to facilitate the performance of statistical analysis. All parameters were examined as dependent against the parameter technique acting as independent to detect potential relationships. The results of multi Y versus X relationship revealed no statistically significant effect (p>0.05) of the three levels of technique against any response considered. Thus we can infer, quite safely, that the innovative operation (level 0) does not differ from the other two conventional methods (levels 2 and 3) through all parameters entered in the model. There was no significant difference between the different pleurodesis techniques. Discussion: Immunotherapy is known to induce in a number of patients pleura effusion and pericarditis. However; pleurodesis is efficient when the appropriate method is performed to every patient. Careful assessment in a case by case manner has to be performed for each patient before any procedure is performed. Ivyspring International Publisher 2020-01-14 /pmc/articles/PMC6995373/ /pubmed/32047566 http://dx.doi.org/10.7150/jca.40004 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Zarogoulidis, Paul
Huang, Haidong
Yang, Meng
Zhou, Jun
Jiao, Yang
Wang, Qin
Petridis, Dimitris
Sapalidis, Konstantinos
Sardeli, Chrysanthi
Konsta, Parthenopi
Koulouris, Charilaos
Michalopoulos, Nikolaos
Giannakidis, Dimitrios
Barbetakis, Nikolaos
Katsaounis, Athanasios
Hohenforst-Schmidt, Wolfgang
Amaniti, Aikaterini
Petanidis, Savvas
Tsakiridis, Kosmas
Courcoutsakis, Nikolaos
Goganau, Alexandru Marian
Vagionas, Anastasios
Romanidis, Konstantinos
Oikonomou, Panagoula
Karanikas, Michael
Katsios, Iason Nikolaos
Kesisoglou, Isaak
Kosmidis, Christoforos
Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
title Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
title_full Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
title_fullStr Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
title_full_unstemmed Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
title_short Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
title_sort pleurodesis and immunotherapy in nsclc; medical thoracoscopy or vats?
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995373/
https://www.ncbi.nlm.nih.gov/pubmed/32047566
http://dx.doi.org/10.7150/jca.40004
work_keys_str_mv AT zarogoulidispaul pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT huanghaidong pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT yangmeng pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT zhoujun pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT jiaoyang pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT wangqin pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT petridisdimitris pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT sapalidiskonstantinos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT sardelichrysanthi pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT konstaparthenopi pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT koulourischarilaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT michalopoulosnikolaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT giannakidisdimitrios pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT barbetakisnikolaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT katsaounisathanasios pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT hohenforstschmidtwolfgang pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT amanitiaikaterini pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT petanidissavvas pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT tsakiridiskosmas pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT courcoutsakisnikolaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT goganaualexandrumarian pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT vagionasanastasios pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT romanidiskonstantinos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT oikonomoupanagoula pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT karanikasmichael pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT katsiosiasonnikolaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT kesisoglouisaak pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats
AT kosmidischristoforos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats